Total Payments
$1,496
2023 Payments
$58.35
Companies
8
Transactions
30
Medicare Patients
1,478
Medicare Billing
$122,264
Payment Breakdown by Category
Food & Beverage$1,496 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,496 | 30 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $532.18 | 10 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $219.67 | 5 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $187.62 | 4 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $172.73 | 3 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $161.98 | 5 | $0 (2023) |
| PORTOLA PHARMACEUTICALS, INC. | $130.81 | 1 | $0 (2019) |
| PFIZER INC. | $47.75 | 1 | $0 (2019) |
| La Jolla Pharmaceutical Company | $43.13 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $58.35 | 3 | AstraZeneca Pharmaceuticals LP ($24.43) |
| 2022 | $253.96 | 3 | AstraZeneca Pharmaceuticals LP ($217.74) |
| 2021 | $425.78 | 11 | AstraZeneca Pharmaceuticals LP ($158.19) |
| 2020 | $161.49 | 6 | Janssen Pharmaceuticals, Inc ($83.55) |
| 2019 | $596.29 | 7 | PORTOLA PHARMACEUTICALS, INC. ($130.81) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.22 | General |
| Category: Cardiovascular | ||||||
| 06/01/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Rare Disease | ||||||
| 01/04/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/10/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $109.55 | General |
| Category: Rare Disease | ||||||
| 09/27/2022 | Alexion Pharmaceuticals, Inc. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $36.22 | General |
| Category: Rare Disease | ||||||
| 03/10/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $108.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $80.05 | General |
| Category: Gastroenterology | ||||||
| 10/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Gastroenterology | ||||||
| 10/15/2021 | Alexion Pharmaceuticals, Inc. | Andexxa (Drug) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: Hematology | ||||||
| 10/12/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.66 | General |
| Category: Cardiovascular | ||||||
| 09/16/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/09/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/08/2021 | Alexion Pharmaceuticals, Inc. | Andexxa (Drug) | Food and Beverage | In-kind items and services | $108.23 | General |
| Category: Hematology | ||||||
| 05/13/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $118.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/16/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/10/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: Gastroenterology | ||||||
| 03/10/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Gastroenterology | ||||||
| 12/07/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/14/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/10/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/01/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/08/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/13/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $52.06 | General |
| Category: Cardiovascular | ||||||
| 11/14/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $102.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $105.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 540 | 553 | $554,024 | $51,107 |
| 2022 | 5 | 625 | 640 | $579,148 | $54,139 |
| 2021 | 5 | 193 | 194 | $59,574 | $8,399 |
| 2020 | 4 | 120 | 122 | $86,216 | $8,618 |
Total Patients
1,478
Total Services
1,509
Medicare Billing
$122,264
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 228 | 237 | $334,542 | $31,509 | 9.4% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 194 | 197 | $195,945 | $17,733 | 9.1% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 25 | 25 | $16,253 | $1,307 | 8.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 93 | 94 | $7,284 | $558.20 | 7.7% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 236 | 241 | $359,674 | $33,895 | 9.4% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 126 | 128 | $129,605 | $12,264 | 9.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 24 | 24 | $43,806 | $4,083 | 9.3% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 48 | 49 | $30,801 | $2,646 | 8.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 191 | 198 | $15,262 | $1,252 | 8.2% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 64 | 64 | $20,884 | $2,971 | 14.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 26 | 26 | $15,078 | $2,474 | 16.4% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 13 | 13 | $14,664 | $1,848 | 12.6% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2021 | 23 | 24 | $5,164 | $732.60 | 14.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 67 | 67 | $3,784 | $373.52 | 9.9% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 34 | 34 | $51,951 | $4,777 | 9.2% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 38 | 38 | $14,513 | $1,856 | 12.8% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 20 | 20 | $18,132 | $1,791 | 9.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 28 | 30 | $1,620 | $194.29 | 12.0% |
About Nathan Bos
Nathan Bos is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/18/2016. The National Provider Identifier (NPI) number assigned to this provider is 1689033649.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nathan Bos has received a total of $1,496 in payments from pharmaceutical and medical device companies, with $58.35 received in 2023. These payments were reported across 30 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,496).
As a Medicare-enrolled provider, Bos has provided services to 1,478 Medicare beneficiaries, totaling 1,509 services with total Medicare billing of $122,264. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Emergency Medicine
- Location Oklahoma City, OK
- Active Since 02/18/2016
- Last Updated 12/01/2023
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1689033649
Products in Payments
- LOKELMA (Drug) $398.20
- ANDEXXA (Biological) $301.01
- ELIQUIS (Drug) $235.37
- RELISTOR (Drug) $219.67
- XARELTO (Drug) $161.98
- Andexxa (Drug) $136.51
- GIAPREZA (Drug) $43.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Oklahoma City
Alexander Frank, M.d, M.D
Emergency Medicine — Payments: $3.1M
Emergency Medicine $3.1M
Mohammad Razaq, M.d, M.D
Emergency Medicine — Payments: $177,813
Emergency Medicine $177,813
Jose Borrego Acosta, Md, MD
Emergency Medicine — Payments: $76,213
Emergency Medicine $76,213
Lindsey Epperson
Emergency Medicine — Payments: $36,931
Emergency Medicine $36,931
Dr. Tyson Quy, M.d, M.D
Emergency Medicine — Payments: $35,983
Emergency Medicine $35,983
Michael Partin, M.d, M.D
Emergency Medicine — Payments: $10,117
Emergency Medicine $10,117